Research study Program year 2020 Source: CMS Open Payments

Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial

Research payments

$32,148

19 payments

Through program year 2020, $32,148 in research payments was reported against Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial, across 19 payments, paid by Ivantis, Inc.

Paid by: Ivantis, Inc
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$32,148	19

Breakdown

Who paid Research payments · program year 2020

Ivantis, Inc $32,148 19 payments

Who received the money Research payments · program year 2020

Brian Flowers Ophthalmology · Fort Worth, TX $12,720 5 payments
Glaucoma Associates Of Texas PA Organisation paid for research $4,395 3 payments
The Eye Center of Racine and Kenosha Organisation paid for research $4,285 3 payments
El Paso Eye Surgeons PA Organisation paid for research $3,903 2 payments
Thomas Samuelson Ophthalmology · Minnetonka, MN $3,455 2 payments
Vold Vision Pllc Organisation paid for research $2,220 3 payments
University Eye Associates Organisation paid for research $1,170 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.